Searchable abstracts of presentations at key conferences in endocrinology

ea0099oc3.6 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Multiple dosing of immediate-release hydrocortisone is associated with a greater risk of hypothalamic-pituitary-adrenal axis suppression when compared to low-dose prednisolone when weaning in steroid-induced adrenal insufficiency

Mifsud Simon , Mifsud Emma Louise , Newell-Price John , Ross Richard , Debono Miguel

Background: Long-term glucocorticoids can result in iatrogenic Cushing’s syndrome with adrenal suppression. Most patients reactivate their hypothalamic-pituitary-adrenal axis once they’re weaned off glucocorticoids. During glucocorticoid withdrawal, many clinicians switch patients to hydrocortisone to benefit from its short half-life1. However, in some patients, hypothalamic-pituitary-adrenal axis recovery is delayed despite the above. It is unclear whethe...

ea0099p503 | Endocrine-Related Cancer | ECE2024

Presurgical lactate dehydrogenase (LDH) levels: A risk factor for disease progression in operated adrenocortical carcinomas

Carreira Ana , Guiomar Joana , Festas Diana , Catarino Diana , Rodrigues Dircea , Moreno Carolina , Melo Miguel , Paiva Isabel

Introduction: Adrenocortical carcinoma (ACC) is a rare malignancy with high recurrence and poor prognosis. Lactate dehydrogenase (LDH) is an enzyme of the glycolytic pathway that is associated with tumour progression in several cancers. To date, evidence on the prognostic value of LDH in ACC is limited.Aims: To assess the impact of LDH in disease-free survival (DFS) in operated ACC.Materials and methods: Retrospective cohort study ...

ea0099p380 | Thyroid | ECE2024

Interrelationships between thyroid function, autoimmunity, low-grade inflammation, lipid profile and insulin resistance in graves’ disease

Neves Celestino , Sergio Neves Joao , Miguel Pereira Luis , Sokhatska Oksana , Queiros Joana , Luis Delgado Jose

Aim: The aim of this study was to evaluate the association between thyroid function in Graves’ disease (GD) with high-sensitivity C-reactive protein (hs-CRP), lipid profile, homocysteine, folate, vitamin B12 and insulin resistance.Methods: We performed a cross-sectional of 104 patients with recently diagnosed GD. All participants were in the first cycle of treatment with methimazole. We collected demographic information, body mass indexes (BMI), lab...

ea0099ep10 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

The diagnosis and treatment of lipodystrophy: the experience of a portuguese tertiary centre

Barbosa Renata , Assuncao Guilherme , Saraiva Miguel , Ferreira Lia , Carvalho Rui , Fonseca Liliana

Introduction: This study presents four clinical cases of lipodystrophies, which are a group of rare and heterogeneous diseases characterized by the decrease or lack of adipose tissue (AT) accompanied by metabolic complications.Clinical cases: 1) 59-year-old woman with partial familial lipodystrophy, type 7 (OMIM #606721): Diagnosis of suspected type 1 diabetes (DM) at 28 (treated with insulin with poor control), class 1 obesity and hypertriglyceridemia. ...

ea0099ep1062 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Importance of the urgent establishment of plasmapheresis in the treatment of pancreatitis induced by extreme hypertriglyceridemia secondary to ketosis-prone type 2 diabetes

Zurdo Lopez Maria , Ruiz-Gines Miguel-Angel , Ruiz-Gines Juan-Antonio , Agudo-Macazaga Mercedes

Introduction: Acute hyperlipidemic pancreatitis is a rare clinical entity that usually affects patients with previous lipid alterations (triglyceride concentration >500 mg/dl) associated with triggering secondary factors, such as poorly controlled diabetes mellitus (DM).Clinical Case: We present the case of a 60-year-old man who came to the Emergency Department with a picture of acute abdominal pain secondary to acute pancreatitis in which a small hy...

ea0063p1106 | Pituitary and Neuroendocrinology 3 | ECE2019

Analysis of gender-related differences in clinically non-functioning pituitary adenomas

Aguirre Moreno Nerea , Sampedro-Nunez Miguel , Levi Ana Ramos , Centeno Rogelio Garcia , Carrera Concepcion Blanco , Escola Cristina Alvarez , Novoa Paz de Miguel , Gutierrez Maria Calatayud , Librizzi Soledad , Azpiroz Monica Marazuela

Introduction: Clinically non-functioning pituitary adenomas (NFPA) are heterogeneous group. Some previous research has found that this type of pituitary adenomas may be smaller and have better prognostic in men. The aim of this study is to analyze if there are gender-related differences in NFPA.Material and methods: Retrospective study of patients with NFPA followed up in regional hospitals (Community of Madrid, Spain). All NFPA had molecular analysis. T...

ea0049ep431 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Vascular dementia and type 2 diabetes: incidence and outcomes in elderly patients in a ten year study

Munoz-Rivas Nuria , Canizo-Gomez Francisco Javier del , Mendez-Bailon Manuel , Andres Ana Lopez-de , de Miguel-Yanes Jose Maria , Hernandez-Barrera Valentin , de Miguel-Diez Javier , Jimenez-Garcia Rodrigo

Background: To describe trends in the incidence and outcomes for vascular dementia in elderly patients with and without type 2 diabetes (T2DM) in Spain between 2004 and 2013.Methods: We used National Hospital Discharge Data to select all patients aged 70 years or over discharged from hospital with a vascular dementia primary diagnosis. Discharges were grouped by diabetes status (T2DM or non-diabetic). Incidence was calculated overall and stratified by di...

ea0070aep722 | Pituitary and Neuroendocrinology | ECE2020

Doses of tolvaptan needed in chronic therapy of SIADH-induced euvolemic hyponatremia vary according to the etiology of SIADH

Pérez Candel Xavier , Lopez Nevado Celia , Cuesta Martin , Angel Rodriguez Cabezas Miguel , Puebla Virginina , de Miguel Paz , Gomez Hoyos Emilia , Ruiz Teresa , Calle Pascual Alfonso , Runkle Isabel

Introduction: Clinical trials indicate that Tolvaptan is safe and effective in the treatment of patients with sustained mild/moderate SIADH-induced euvolemic hyponatremia. Tolvaptan doses are often modified during chronic use. We present the weekly doses of a series of patients on chronic therapy, followed up in outpatient clinic.Methods: Retrospective, cross-sectional. 114 patients receiving tolvaptan for chronic SIADH were followed up in a Hyponatremia...

ea0099p291 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Endoscopic argon plasma coagulation (APC) treatment for dumping syndrome and post-bariatric hypoglucemia in patients with ROUX-EN-Y gastric bypass

Mera Carreiro Sara , Bernaldo Madrid Blanca , Rodriguez Carrillo Clara , Espinosa De Los Monteros Patricia , Avila Anton Laura , Sanchez-Maroto Garcia Noelia , Martinez Suero Laura , Rueda Ortin Teresa , Miguel Esteban Lopez-Jamar Jose , Angel Rubio Herrera Miguel

Background: Dumping syndrome (DS) and post-bariatric hypoglycemia (PBH) are some of the most challenging problems encountered during the follow-up of bariatric surgery (BS), especially after Roux-en-y gastric bypass (yRGB). When pharmacological and dietary treatment fail to control DS and PBH, surgical revision is often the next therapeutic step. Endoscopic treatment with argon plasma coagulation (APC) may be an alternative treatment by reducing the diameter of the gastro-jeju...

ea0081p580 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Hypoglycemia and impared hypoglycemia awareness: frequency and relevance in type 1 diabetes under continuous subcutaneous insulin infusion

Mafalda , Carreira Ana , Vieira Ines , Barros Luisa , Melo Miguel , Rodrigues Dircea , Oliveira Patricia , Baptista Carla , Moreno Carolina , Paiva Isabel

Introduction: Continuous subcutaneous insulin infusion (CSII) therapy in type 1 diabetes (T1D) reduces the risk of hypoglycemia. Hypoglycemia remains a treatment-limiting factor. Impared hypoglycemia awareness (IHA) occurs in 25% of T1D cases and seems to be underestimated by continuous glucose monitoring (CGM). Glycemic variability (GV) is a increasingly valued parameter as a predictor of hypoglycemia and risk of chronic complications.Objective: Analysi...